Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
Investigators will evaluate and compare the efficacy of Sitagliptin/Metformin to metformin and sitagliptin on gdf9 and bmp15 gene expression on PCOS patients undergoing intracytoplasmic sperm injection(ICSI).
Polycystic Ovary Syndrome|Infertility|ART
DRUG: placebo|DRUG: metformin|DRUG: Sitagliptin|DRUG: Sitagliptin/metformin
Fasting insulin, ELIZA hormone assay, 24 hours after last dose|Growth differentiation factor-9(GDF-9) expression, Realtime PCR, 24 hours after last dose|Bone morphogenetic protein-15(BMP-15) expression, Realtime PCR, 24 hours after last dose|Total Testosterone, ELIZA hormone assay, 24 hours after last dose|Follicle-stimulating hormone(FSH), ELIZA hormone assay, 24 hours after last dose
This study was conducted in Infertility clinic of Mahdiyeh Educational Hospital, Tehran. Patients in the four groups receive the drug 2 months before the start of the ovulation cycle, and treatment will continue until the day of the oocyte aspiration. The drug provide by midwife to patients and both patient and physician blind to the treatment regimen. The participants randomly divide into four groups.The ovulation induction stimulate with GnRh antagonist.